This reminds me of the post July 22 presentation when the stock sold off immediately following the PR and then started to climb on huge volume once the sellers who didn't understand what was going on had exited.
There is a ton of volume and attention on AVXL. This is the immediate reaction to the results. There is still a lot of potential in AVXL 2-73, as well as the company's other compounds. It just needs more clinical affirmation. Anyway, definitely cooler heads will prevail after today. We'll see how it shakes out.